Lexicon Pharmaceuticals LXRX Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- Lexicon Pharmaceuticals (LXRX) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -17.6% in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- The percentage impact on the effective tax rate caused by adjustments to the valuation allowance for deferred tax assets. This metric quantifies the impact of changes in tax asset recoverability estimates on the company's reported tax rate.